Residential Treatment Compared With Outpatient Treatment for Tobacco Use and Dependence

Hays, J. Taylor; Croghan, Ivana T.; Schroeder, Darrell R.; Burke, Michael V.; Ebbert, Jon O.; McFadden, David D.; Hurt, R. Douglas

doi:10.4065/mcp.2010.0703

Cited by 28 publications

(48 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A 4-day residential program for tobacco dependence by Green et al 17 reported a 6-month abstinence rate of about 26%. Results from the Mayo Clinic 8-day residential smoking cessation program indicate higher self-reported 7-day point prevalence smoking abstinence for the residential (45%) versus outpatient (26%) groups at 6 months 19 . In contrast to the Mayo Clinic, which is a referral centre, our service is a primary care setting and the smokers are entirely self-referred through our quit-smoking hotline.…”

Section: Discussionmentioning

confidence: 93%

Pilot study of a 3-day residential treatment for smoking cessation in Hong Kong

Ho¹,

Fok²,

Chan³

2018

Tob. Prev. Cessation

View full text Add to dashboard Cite

INTRODUCTION The Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation has been providing free smoking cessation services since 2009. The average quit rate from 2009 to 2014 was 37%. In order to boost the quite rate, we have implemented a residential treatment program for smokers who volunteered to participate. Having run the program for two years, we conducted a retrospective cohort study to evaluate its effectiveness. METHODS We recruited the participants who had failed previous quit attempts and who came to seek our smoking cessation services. A 3-day residential program of activities were arranged for our participants. Intensive individual and group counseling was provided. Pharmacotherapy was also provided to alleviate withdrawal symptoms. This was followed by our usual treatment and follow-up program. Self-reported 7-day point prevalence abstinence rate at 26 weeks based on intention-to-treat (ITT) analysis was assessed. RESULTS A total of 40 clients volunteered to join the program, age 26 to 65 years old with a mean of 44.1 years. There were 25 (62.5%) males and 15 (37.5%) females. The quit rate at 26 weeks was 57.5%. Smokers older than 43 years, having cohabiting smokers, and smoking for more than 28 years, were more likely to quit and this was statistically significant. CONCLUSIONS This pilot study demonstrated that a 3-day residential program is effective in helping addicted smokers who volunteer to quit smoking and is cost effective compared to longer residential programs.

show abstract

Section: Discussionmentioning

confidence: 93%

Pilot study of a 3-day residential treatment for smoking cessation in Hong Kong

Ho¹,

Fok²,

Chan³

2018

Tob. Prev. Cessation

View full text Add to dashboard Cite

show abstract

“…For example, evidence suggests that providing monetary incentives to substance users to "practice" quitting (i.e., contingency management) increases cessation-related self-confidence and the probability of later abstinence (see Higgins, Badger, & Budney, 2000;Higgins et al, 2006). Providing tobacco cessation treatment during brief (8-day) inpatient hospitalization programs has also been shown to produce impressive long-term abstinence rates (Hays et al, 2011;Hodgkin et al, 2013). There may be value to incorporating these behavioral approaches into third-wave mindfulness and acceptance-based therapies as a means of effectively challenging unhelpful, non-accepting beliefs about cravings and distress tolerance.…”

Section: Discussionmentioning

confidence: 96%

Acceptance of cravings: How smoking cessation experiences affect craving beliefs

Nosen

Woody

2014

Behaviour Research and Therapy

View full text Add to dashboard Cite

“…The essential clinical paradox is that, although all FDA-approved tobaccodependence medications are effective in producing abstinence in a dose-dependent fashion (203,204), practical effectiveness appears to have recently declined because of issues such as underdosing, poor product use technique, and lack of physician guidance (205)(206)(207). Attention to proper dosing, treatment duration, and individualized combination pharmacotherapy strategies, coupled with advice to assuage patient concerns regarding side effects (208), can boost abstinence rates from 3 to 6% for unsupported cold-turkey attempts (70,195,197) to nearly 60% with full multimodal assistance (209)(210)(211)(212)(213).…”

Section: What We Knowmentioning

confidence: 98%